Oral Cancer Risk Screening Calculator

This calculator builds an illustrative Risk Score by adding weighted points for five factors, then reads that total against four bands to set a Screening Recommendation. HPV Risk carries the largest single weight of any factor here (9 points for known HPV-16 positivity, the biggest jump any one input can cause) -- HPV-16 carries a substantially higher relative risk than tobacco specifically for oropharyngeal cancer (D'Souza et al. 2007, NEJM 356:1944-56, odds ratio 14.6-32.2) than tobacco's own measured effect (Hashibe et al. 2007, JNCI 99:777-89, odds ratio ~2.13 in never-drinkers). The ADA describes HPV as "a major risk factor for oropharyngeal cancer, rather than oral cancer, per se" -- this calculator's Risk Score does not separate oral-cavity from oropharyngeal risk, so treat the HPV weight as reflecting that site-specific effect, not a general oral-cavity multiplier. Tobacco Use still carries a substantial weight (5 points for current use) and remains the most well-established modifiable risk factor across the broader oral cancer literature, even though its own measured odds ratio is smaller than HPV-16's oropharyngeal-specific figure.

Patient Age adds points in steps -- 2 at 40, 3 at 50, 4 at 60 -- and stops adding any further points once age reaches 60, so a 60-year-old and a 90-year-old score identically on age alone even though real-world risk continues to vary with age beyond that point. An extra 3-point synergy bonus is added whenever Tobacco Use and at least Moderate Alcohol Use are both present, reflecting the widely cited combined risk of tobacco and alcohol together exceeding either factor alone. This Risk Score is a general educational synthesis of known risk-factor directions, not a validated, published risk-scoring instrument with its own citation and cutoffs the way HEART or CURB-65 are -- treat Risk Level and Screening Recommendation as a prompt to discuss individual risk with a clinician, not as a diagnostic result. Screening Recommendation always names conventional visual and tactile examination at a risk-scaled interval, which is what the ADA's current living clinical practice guideline actually endorses for asymptomatic adults -- the same guideline explicitly recommends AGAINST using light-based fluorescence devices, vital (toluidine blue) staining, or brush cytology to screen or triage asymptomatic adults, so this calculator does not recommend those adjunctive technologies at any risk band. USPSTF separately rates oral cancer screening Grade I (insufficient evidence to assess the balance of benefits and harms), a rating issued in 2013 and last reaffirmed in 2023. Regardless of Risk Level, any oral lesion that persists more than two weeks warrants biopsy or specialist referral -- that threshold does not depend on the risk-factor score.